Capstone Turbine Corp., a leading producer of low-emission microturbine systems, today announced it has received an order for a C1000 and C200 for use at a large World Health Organization (WHO) certified Nigerian pharmaceutical company.
The pharmaceutical company will use Capstone’s microturbine systems to provide power and thermal energy for the manufacturing process. It will also improve plant efficiency while reducing its carbon footprint.
The order follows a recent meeting with a delegation of the Nigerian government and business leaders led by the U.S. Ambassador to Nigeria, in which discussions centered on how expanding the number of Capstone microturbines in Nigeria can benefit the country’s economy.
“The meeting was a big success as indicated by this order,” Jim Crouse, Capstone’s executive vice president of Sales and Marketing stated in the press release. “The meeting provided a tremendous opportunity for Capstone to support the U.S. government’s National Export Initiative and grow our sales throughout Nigeria, especially in the industrial and oil & gas markets.”
Capstone’s distribution partner Makon Power Systems Ltd. will head the installation, commissioning and aftermarket support for the system, and represents Makon’s second multiple unit order and first purchase of Capstone’s C200 and C1000 products.
“We expect several additional orders greater than a megawatt for industrial and oil & gas customers in Nigeria in the months to follow,” said Ademola Ajakaye, Makon’s chief operating officer.
For more information visit www.capstoneturbine.com
About MissionIR:
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html
